Transcatheter Aortic Valve Replacement News and Research

RSS

Initial benefit of TAVR remains consistent over the first three years among patients at low surgical risk

The number of deaths and disabling strokes among patients at low surgical risk who were treated with transcatheter aortic valve replacement (TAVR) remained lower at three years, but not significantly lower, following the TAVR procedure compared with patients who received conventional surgical aortic valve replacement (SAVR), according to new data being presented at the American College of Cardiology's Annual Scientific Session Together With the World Congress of Cardiology.

5 Mar 2023

OpSens Announces SavvyWire™ Used During Two Live Cases at CRT Conference

Quebec City, Quebec, February 28, 2023 – OpSens Inc. (“OpSens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF), a medical device cardiology-focused company delivering innovative solutions based on its proprietary optical technology, is pleased to announce the inaugural two SavvyWire live case broadcasts occurred on Monday, February 27, 2023, during the Cardiovascular Research Technologies (CRT) conference.

From OpSens Medical 1 Mar 2023

Morristown Medical Center reaches significant milestone of performing over 4,000 TAVR

Morristown Medical Center's Gagnon Cardiovascular Institute's structural heart program reached a significant milestone of performing over 4,000 transcatheter aortic valve replacement (TAVR) procedures with well over 650 in 2022 alone.

10 Feb 2023

Cedars-Sinai experts to present innovative heart research data during AHA Scientific Sessions 2022

During American Heart Association Scientific Sessions 2022, Prominent Cedars-Sinai Cardiologists, Cardiothoracic Surgeons and Interventionalists Available for Interviews

3 Nov 2022

Minimally invasive procedure enables patients to be out of the hospital within a few days

Minimally invasive, catheter-based transcatheter aortic valve replacement (TAVR) has revolutionized treatment of aortic stenosis (AS), and both American and European guidelines have approved its use. However, there is a perception that TAVR is more expensive than surgical aortic valve replacement (SAVR). A budget impact analysis comparing the two options now shows that TAVR is an affordable and effective strategy for the treatment of AS. The study appears in the Canadian Journal of Cardiology, published by Elsevier.

12 Sep 2022

New risk assessment tool predicts mortality for atrial fibrillation patients after completion of TAVR

A large-scale international study led by Mount Sinai has yielded the first risk score that can help predict mortality for patients with atrial fibrillation (AFib) who have undergone a successful transcatheter aortic valve replacement (TAVR) and discharged home.

29 Aug 2022

Patients treated with edoxaban after TAVR do not find reduction in mini strokes, blood clots in the brain

Patients treated with the blood thinner edoxaban for six months after a heart valve replacement procedure experienced fewer symptomless blood clots inside the heart valve replacement than patients who were treated with two antiplatelet drugs, according to data presented at the American College of Cardiology's 71st Annual Scientific Session.

5 Apr 2022

Trial finds similar five-year outcomes with transcatheter or surgical aortic valve replacement

New five-year data from the SURTAVI trial found that there was no difference in all-cause mortality or stroke between patients at intermediate surgical risk who had transcatheter aortic valve replacement (TAVR) or surgery.

8 Nov 2021

Cardiac CTA parameters predict mortality after transcatheter aortic valve replacement

According to ARRS' American Journal of Roentgenology (AJR), cardiac CTA-derived left atrium emptying fraction (LAEF) improves predictive performance of established clinical risk scores and may be used to assess patients' risk during pre-transcatheter aortic valve replacement (TAVR) workup and postprocedural surveillance.

13 Oct 2021

Study finds no difference in physician-patient gender concordance

While some studies suggest female patients treated by female physicians have better outcomes, there does not appear to be a relationship between operator and patient gender and outcome in patients undergoing coronary angioplasty or stenting. T

26 May 2021

Scoring system can help improve the diagnosis of concomitant heart diseases

Aortic stenosis is one of the most common heart valve defects. Its prevalence increases with age and it often requires treatment.

24 Nov 2020

Researchers develop new scoring system to screen for dual heart disease

Aortic stenosis is one of the most common heart valve defects. Its prevalence increases with age and it often requires treatment.

24 Nov 2020

REFLECT II clinical trial evaluates safety and efficacy of cerebral embolic deflection filter

The REFLECT II randomized clinical trial evaluating the safety and efficacy of a device designed to reduce cerebral embolization and ischemic stroke, complications of transcatheter aortic valve replacement (TAVR), found that the device met the primary safety endpoint compared to historical controls but did not demonstrate superiority of the device for the primary hierarchical efficacy endpoint.

16 Oct 2020

New self-expanding bioprosthetic valve used in TAVR fails to demonstrate non-inferiority

In a randomized clinical trial, SCOPE II, a new self-expanding bioprosthetic valve used in transcatheter aortic valve replacement (TAVR) failed to demonstrate non-inferiority compared to an existing self-expanding valve.

16 Oct 2020

3D-printed organ model can improve surgical outcomes for heart patients

Researchers from the University of Minnesota, with support from Medtronic, have developed a groundbreaking process for multi-material 3D printing of lifelike models of the heart's aortic valve and the surrounding structures that mimic the exact look and feel of a real patient.

28 Aug 2020

TAVR market shows hopeful signs of resiliency, says GlobalData

“Following Edwards Lifesciences’ announcement of an expected 5% growth for its transcatheter aortic valve replacement (TAVR) business, GlobalData observes hopeful signs of resiliency in the TAVR market.

31 Jul 2020

Thinner tissues induce problematic flutter in aortic heart valve replacements

You're in the middle of the aorta, the body's pipeline for oxygen-rich blood, looking back toward the heart's primary pump, the left ventricle.

29 Jul 2020

COVID-19 and blood group in aortic valve replacement

The COVID-19 pandemic has been found to cause disproportionate harm in patients with cardiovascular disease, especially among the elderly population, among other risk factors. However, a new study published on the preprint server medRxiv* in June 2020 is the first to report its clinical features in patients with aortic stenosis who have had a transcatheter aortic valve replacement (TAVR).

18 Jun 2020

UC physician-researcher explores why TAVR doesn't work well for some patients

A University of Cincinnati physician-researcher says unlocking the key to how platelets function before, after and during transcatheter aortic valve replacement (TAVR) may provide insight as to why some patients undergoing the heart procedure have better outcomes than others.

3 Jun 2020

New study highlights inequity in access to TAVR procedure across Canada

Transcatheter aortic valve replacement is a revolutionary technology for the treatment of patients with severe calcific aortic stenosis.

30 Apr 2020